Small Cell Lung Cancer - Epidemiology Insights to 2025

Publisher Name :
Date: 28-Jul-2017
No. of pages: 40
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Small Cell Lung Cancer -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Small Cell Lung Cancer in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Small Cell Lung Cancer. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Small Cell Lung Cancer. The report contains the targeted patient populations and the forecast methodology.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Key Coverage and Benefits

  • The Report includes the prevalent population and how will it change over the next eight years.

  • Coverage of key Small Cell Lung Cancer sub-populations and its prevalent or incident cases

  • Prevalent or incident cases segmented by age and sex.

  • The key differences in epidemiology patterns across the seven market segments.

Reasons to buy

  • Developing business strategies by understanding the trends shaping and driving the global Small Cell Lung Cancer market.

  • Identifying prevalent patient populations as well as risk factors in the global Small Cell Lung Cancer market will help to improve product design, pricing, and launch plans.

  • Organize sales and marketing efforts by identifying the best opportunities for Small Cell Lung Cancer therapeutics in each of the markets covered.

Small Cell Lung Cancer - Epidemiology Insights to 2025

Table of Contents

1. Report Introduction

2. Snapshot of Total Prevalent or Incident cases by 7 MM

3. Executive Summary
Key Findings

4. Small Cell Lung Cancer Overview
Small Cell Lung Cancer Definition
Pathophysiology
Symptoms
Etiology

5. Risk Factors Associated with Small Cell Lung Cancer

6. Disease Burden & Unmet Need in the Market

7. Epidemiology and Patient Populations
Key Findings
Key Sources used and Forecast Methodology
Prevalent Cases and Incident Cases-2015-2025
Prevalent & Incident Cases by Category-2015-2025
Age-Specific Prevalent/ Incident Cases of Small Cell Lung Cancer
Sex-Specific Prevalent/Incident Cases of Small Cell Lung Cancer
Disease Type Specific Prevalent/Incident Cases of Small Cell Lung Cancer

8.Prevalent & Incident Cases by 7 MM-2015-2025
Small Cell Lung Cancer Epidemiology of United States-2025
Small Cell Lung Cancer Epidemiology of United Kingdom-2025
Small Cell Lung Cancer Epidemiology of Germany-2025
Small Cell Lung Cancer Epidemiology of France-2025
Small Cell Lung Cancer Epidemiology of Spain-2025
Small Cell Lung Cancer Epidemiology of Italy-2025
Small Cell Lung Cancer Epidemiology of Japan-2025

9. Key Takeaways

10. Appendix

11.Report Methodology

12. Consulting Services

13. Disclaimer

14. About Us

List of Tables

Table 1: Clinical subtypes of Indication
Table 2: Risk Factors
Table 3: Prevalence cases (%) Region wise
Table 4: Sources used for forecasting the data
Table 5: Small Cell Lung Cancer Global Epidemiology, (2015-2025)
Table 6: Prevalent Cases of Small Cell Lung Cancer (Ages =XX Years), US (2015-2025)
Table 7: Prevalent Cases of Small Cell Lung Cancer By Sex (Males & Females), US (2015-2025)
Table 8: Prevalent Cases By Small Cell Lung Cancer Sub-population, US (2015-2025)
Table 9: Prevalent Cases of Small Cell Lung Cancer (Ages =XX Years), United Kingdom (2015-2025)
Table 10: Prevalent Cases of Small Cell Lung Cancer By Sex (Males & Females), United Kingdom (2015-2025)
Table 11: Prevalent Cases By Small Cell Lung Cancer Sub-population, United Kingdom (2015-2025)
Table 12: Prevalent Cases of Small Cell Lung Cancer (Ages =XX Years), Germany (2015-2025)
Table 13: Prevalent Cases of Small Cell Lung Cancer By Sex (Males & Females), Germany (2015-2025)
Table 14: Prevalent Cases By Small Cell Lung Cancer Sub-population, Germany (2015-2025)
Table 15: Prevalent Cases of Small Cell Lung Cancer (Ages =XX Years), France (2015-2025)
Table 16: Prevalent Cases of Small Cell Lung Cancer By Sex (Males & Females), France (2015-2025)
Table 17: Prevalent Cases By Small Cell Lung Cancer Sub-population, France (2015-2025)
Table 18: Prevalent Cases of Small Cell Lung Cancer (Ages =XX Years), Italy (2015-2025)
Table 19: Prevalent Cases of Small Cell Lung Cancer By Sex (Males & Females), Italy (2015-2025)
Table 20: Prevalent Cases By Small Cell Lung Cancer Sub-population, Italy (2015-2025)
Table 21: Prevalent Cases of Small Cell Lung Cancer (Ages =XX Years), Spain (2015-2025)
Table 22: Prevalent Cases of Small Cell Lung Cancer By Sex (Males & Females), Spain (2015-2025)
Table 23: Prevalent Cases By Small Cell Lung Cancer Sub-population, Spain (2015-2025)
Table 24: Prevalent Cases of Small Cell Lung Cancer (Ages =XX Years), Japan (2015-2025)
Table 25: Prevalent Cases of Small Cell Lung Cancer By Sex (Males & Females), Japan (2015-2025)
Table 26: Prevalent Cases By Small Cell Lung Cancer Sub-population, Japan (2015-2025)

List of Figures

Figure 1: Prevalence cases (%) Region wise
Figure 2: Sources used for forecasting the data
Figure 3: Small Cell Lung Cancer Global Epidemiology, (2015-2025)
Figure 4: Prevalent Cases of Small Cell Lung Cancer (Ages =XX Years), US (2015-2025)
Figure 5: Prevalent Cases of Small Cell Lung Cancer By Sex (Males & Females), US (2015-2025)
Figure 6: Prevalent Cases By Small Cell Lung Cancer Sub-population,US (2015-2025)
Figure 7: Prevalent Cases of Small Cell Lung Cancer (Ages =XX Years), United Kingdom (2015-2025)
Figure 8: Prevalent Cases of Small Cell Lung Cancer By Sex (Males & Females), United Kingdom (2015-2025)
Figure 9: Prevalent Cases By Small Cell Lung Cancer Sub-population,United Kingdom (2015-2025)
Figure 10: Prevalent Cases of Small Cell Lung Cancer (Ages =XX Years), Germany (2015-2025)
Figure 11: Prevalent Cases of Small Cell Lung Cancer By Sex (Males & Females), Germany (2015-2025)
Figure 12: Prevalent Cases By Small Cell Lung Cancer Sub-population,Germany (2015-2025)
Figure 13: Prevalent Cases of Small Cell Lung Cancer (Ages =XX Years), France (2015-2025)
Figure 14: Prevalent Cases of Small Cell Lung Cancer By Sex (Males & Females), France (2015-2025)
Figure 15: Prevalent Cases By Small Cell Lung Cancer Sub-population,France (2015-2025)
Figure 16: Prevalent Cases of Small Cell Lung Cancer (Ages =XX Years), Italy (2015-2025)
Figure 17: Prevalent Cases of Small Cell Lung Cancer By Sex (Males & Females), Italy (2015-2025)
Figure 18: Prevalent Cases By Small Cell Lung Cancer Sub-population,Italy (2015-2025)
Figure 19: Prevalent Cases of Small Cell Lung Cancer (Ages =XX Years), Spain (2015-2025)
Figure 20: Prevalent Cases of Small Cell Lung Cancer By Sex (Males & Females), Spain (2015-2025)
Figure 21: Prevalent Cases By Small Cell Lung Cancer Sub-population,Spain (2015-2025)
Figure 22: Prevalent Cases of Small Cell Lung Cancer (Ages =XX Years), Japan (2015-2025)
Figure 23: Prevalent Cases of Small Cell Lung Cancer By Sex (Males & Females), Japan (2015-2025)
Figure 24: Prevalent Cases By Small Cell Lung Cancer Sub-population,Japan (2015-2025)
  • Global Chronic Lymphocytic Leukemia Therapeutics Market Size, Status and Forecast 2025
    Published: 09-Jan-2018        Price: US 3300 Onwards        Pages: 91
    This report studies the global Chronic Lymphocytic Leukemia Therapeutics market, analyzes and researches the Chronic Lymphocytic Leukemia Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Pfizer - Amgen - Abbott - Roche AG - Novartis - Johnson and Johnson - Sanofi Genzyme Corporation - Akebia Therapeutics - Celgene......
  • Global Lung Cancer Therapeutics Market Size, Status and Forecast 2025
    Published: 09-Jan-2018        Price: US 3300 Onwards        Pages: 98
    This report studies the global Lung Cancer Therapeutics market, analyzes and researches the Lung Cancer Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Pfizer - Roche - Merck - AstraZeneca - Sanofi-Aventis - Eli Lilly and Company - Abbott - Akebia Therapeutics - Agennix AG Market segment by Regions......
  • Gene Therapy for Ovarian Cancer- A Pipeline Analysis Report
    Published: 05-Jan-2018        Price: US 3500 Onwards        Pages: 73
    Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor, and stromal ovarian tumor are some of the less common types. It is the seventh most common cancer in women globally and 18th most common cancer overall. The ovarian cancer immunotherapies market ......
  • Medulloblastoma - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 197
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Medulloblastoma - Pipeline Review, H2 2017, provides an overview of the Medulloblastoma (Oncology) pipeline landscape. Medulloblastoma is the most common malignant brain tumor in children. Medulloblastoma by definition occur in the cerebellum, which is the part of brain located at the base of the skull, just above the brainstem. Symptoms associated with a medulloblastoma include headaches in the mo......
  • High-Grade Glioma - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 333
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide High-Grade Glioma - Pipeline Review, H2 2017, provides an overview of the High-Grade Glioma (Oncology) pipeline landscape. Highly grade gliomas (HGG) are tumors of the central nervous system (CNS) that arising from transformed cells of the brain and spinal cord. Symptoms include developmental delay, headaches, backaches, nausea and vomiting, dizziness, gait disturbances, impaired vision, lack of co......
  • Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 766
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2017, provides an overview of the Bile Duct Cancer (Cholangiocarcinoma) (Oncology) pipeline landscape. Bile duct cancer or cholangiocarcinoma are tumors that occur in the bile duct. Symptoms include discomfort in the tummy area (abdomen), loss of appetite, high temperatures (fevers) and weight loss. Treatment includes chemotherapy and radi......
  • Colorectal Cancer - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2500 Onwards        Pages: 1962
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer - Pipeline Review, H2 2017, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape. Colorectal cancer is a cancer that starts in the colon or the rectum. Colorectal cancers begin as a growth called a polyp on the inner lining of the colon or rectum. Symptoms include abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation,......
  • Pancreatic Cancer - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2500 Onwards        Pages: 2270
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer - Pipeline Review, H2 2017, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape. Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas. This is also called exocrine cancer. Signs and symptoms include upper abdominal pain that may radiate to back, yellowing of skin and the whites of eyes (jaundice), loss of......
  • Ovarian Cancer - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2500 Onwards        Pages: 2232
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer - Pipeline Review, H2 2017, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape. Ovarian cancer is any cancerous growth that may occur in different parts of the ovary. The majority of ovarian cancers arise from the epithelium (outer lining) of the ovary. Signs and symptoms of ovarian cancer include pelvic discomfort or pain, indigestion, gas or nausea, changes in......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs